Join us for an overview of state-of-the-art proteomics panels and guidance on which ones are most suited for different health research studies. Our Scientific Director Peter Würtz will discuss strengths and limitations of the various Olink and Alamar NULISA proteomics panels offered by Nightingale Health. We will also explore how metabolomics and proteomics complement each other in population health research, illustrated through analyses on UK Biobank and other studies. Finally, we will showcase opportunities for multiomics profiling from dried blood spot samples suited for remote collection.

 

After the 30-minute presentation, there will be time for questions.